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Abstract 9 
Objectives: To describe the use of a xenotransfusion protocol, the outcome of xenotransfusion in recipient 10 
cats and to assess owner memory of the xenotransfusion. 11 
Methods: Cats administered xenotransfusions in two hospitals between January 2016 and July 2018 were 12 
included. Adherence to xenotransfusion protocol, cause of anaemia, blood type, packed cell volume (PCV), 13 
transfusion volume, transfusion reactions, PCV 12 hours after transfusion and survival to discharge were 14 
recorded. Owners of surviving cats were questioned to assess if they remembered that a xenotransfusion had 15 
been performed. 16 
Results: Forty‐nine cats underwent the xenotransfusion protocol. The most common causes of anaemia were 17 
surgical blood loss (n = 17), immune‐mediated haemolytic anaemia (n = 14) and neoplasia (n = 14). Median 18 
PCV before transfusion was 10%. Six cats (12%) had febrile non‐haemolytic transfusion reactions. Median PCV 19 
12 hours after transfusion was 25%. Ten cats (20%) died or were euthanased within 24 hours of 20 
xenotransfusion. A delayed haemolytic transfusion reaction occurred in 25 of 39 (64%) cats manifesting as 21 
icterus in 15 cats after a median of 1.9 days and haemolytic serum in 19 cats after a median of 2 days. Of the 22 
18 cats alive at 1 week after discharge, 15 (83%) were still alive at a median of 173 days after xenotransfusion. 23 
All owners contacted remembered that their cats had received a xenotransfusion.  24 
Clinical significance: Xenotransfusion of canine blood to cats is possible but haemolysis should be expected 25 
between 1 and 6 days post transfusion. Repeat transfusion with feline blood is often required.  26 
Introduction 27 
Xenotransfusion of canine blood to cats is a recognised veterinary technique, having been used to treat 28 
anaemic cats in emergencies when compatible feline blood was not available (Oron et al. 2017, Bovens & 29 
Gruffydd‐Jones 2013). Although in vitro data suggest that transfusion of cats with dog blood could cause an 30 
acute haemolytic transfusion reaction (Euler et al. 2016, Priolo et al. 2018), no severe acute adverse 31 
reactions have been reported in cats receiving a single canine blood transfusion (Bovens & Gruffydd‐Jones 32 
2013, Klainbart et al. 2018). However, delayed haemolytic transfusion reactions are frequent and fatal 33 
anaphylaxis has been described following repeated xenotransfusion (Hessler et al. 1962, René 1968, Lautié 34 
et al. 1969, Bovens & Gruffydd‐Jones 2013). Despite this, canine to feline xenotransfusion has regained 35 
popularity because of the withdrawal of Oxyglobin from the market and the relative difficulty of sourcing 36 
feline blood donors. Although there have been some recent clinical reports of successful xenotransfusion 37 
(Oron et al. 2017, Weingram et al. 2014, Klainbart et al. 2018), large studies and literature regarding the peri‐38 
transfusion time period, long‐term follow‐up and owner awareness of the significance of xenotransfusion 39 
are lacking. 40 
 41 
Indications for feline transfusion with feline blood products have been well described (Barfield & Adamantos 42 
2011), but no protocol has been described to help clinicians decide when xenotransfusion is appropriate. 43 
Reported clinical indications for xenotransfusion include previous transfusion reaction to feline blood (Euler 44 
et al. 2016), insufficient time to blood type the recipient (Oron et al. 2017), non‐readily available compatible 45 
feline blood products (Oron et al. 2017, Weingram et al. 2014, Euler et al. 2016, Klainbart et al. 2018), 46 
financial constraints (Weingram et al. 2014, Klainbart et al. 2018) and life‐threatening emergencies (Oron 47 
et al. 2017, Euler et al. 2016, Klainbart et al. 2018). 48 
 49 
The aims of this study were to describe a xenotransfusion protocol and assess adherence to this protocol, to 50 
describe the clinical situations in which xenotransfusion was used, to determine crossmatch compatibility 51 
between canine donors and feline recipients and its relevance, to describe the short‐ and long‐term 52 
outcomes of cats administered a xenotransfusion, and to determine whether owners remembered that their 53 
cat had received a xenotransfusion and that repeat xenotransfusion was contraindicated. 54 
 55 
Material and methods: 56 
This was a prospective observational study. All cats receiving a xenotransfusion at two university teaching 57 
hospitals between January 2016 and July 2018 were enrolled in the study. In case of unavailability of 58 
appropriate feline blood products or donors, a xenotransfusion protocol was applied, that required fulfilment 59 
of set criteria (document 1, Supporting Information). If the clinicians involved in the case considered the cat 60 
likely to die within 6 hours without blood product administration due to the severity of their clinical signs they 61 
were considered potential candidates for transfusion. In the absence of suitable feline blood products, the 62 
clinicians then had to ensure the cat had never been administered dog blood previously and obtain informed 63 
consent for xenotransfusion from the owners. A member of the hospital Transfusion Medicine Service had to 64 
review the case and agree to the patient's suitability for xenotransfusion. The owners were then informed of 65 
the risks of sudden death, rapid haemolysis and likely requirement for a subsequent transfusion with feline 66 
blood products. They were also informed that xenotransfusion could not be repeated. For the cats that were 67 
discharged, written instructions that reiterated this information were given to the owners. 68 
 69 
Adherence to the xenotransfusion protocol, recipient signalment, pre‐transfusion PCV, cause of anaemia, 70 
xenotransfusion volume and survival to discharge were recorded. Blood type, PCV after transfusion and 71 
creatinine before and after transfusion were recorded when clinically possible. The recipients and donors were 72 
typed using a commercial immunochromatographic test (respectively Lab test QuickTest A + B and dog 73 
erythrocyte antigen (DEA) 1, Alvedia, Limonest, France). One millilitre of packed red blood cells per kilogram 74 
was transfused for every percentage point of PCV increase desired, generally aiming for a PCV after transfusion 75 
of 25%, although the decision was left to the attending clinician. When sufficient recipient blood was available, 76 
both major and minor crossmatches were performed. Crossmatches were performed by trained personnel 77 
using washed erythrocytes and a standard slide crossmatch technique as previously described (Tocci & Ewing 78 
2009) although, due to the emergent situations in which the xenotransfusions were performed, crossmatch 79 
results were not available before administration. 80 
 81 
A standard transfusion monitoring sheet was used during the transfusion, to record temperature, pulse, 82 
respiration rate, mucous membrane colour, capillary refill time, urine colour (if applicable), appearance and 83 
demeanour at least hourly starting with a baseline before starting the transfusion. The transfusion was 84 
administered via syringe and in‐line filter (Hemo‐Nate) on a syringe driver at 1 mL/kg/hour for the first 85 
30 minutes and then increased to allow each syringe of blood to be given over no longer than 6 hours, with 86 
further syringes being administered as required to provide the volume desired by the attending clinician. After 87 
the end of the transfusion the patient was monitored as required by the attending clinician with a minimum 88 
of once daily full physical examination including body temperature, pulse and respiration assessment until 89 
discharge from hospital. Recipient PCV was measured 12 hours after the end of the xenotransfusion when 90 
possible. Acute development of urticaria, angioedema or pruritus during the transfusion was recorded as a 91 
suspected allergic reaction. If a recipient had an increase in rectal temperature of greater than 1°C from 92 
baseline at the beginning of the transfusion, non‐pathological reasons including external warming and 93 
recovery from general anaesthesia were considered. If no such reason was found, then recipient serum and 94 
packed red blood cell supernatant (obtained via centrifugation of haematocrit tubes) were checked for 95 
haemolysis (as was recipient urine, if available) and, if present, a haemolytic transfusion reaction was 96 
suspected. If absent, the blood product was cytologically examined for bacteria and cultured. If abnormalities 97 
were noted the transfusion was stopped and a suspected septic transfusion was recorded. If neither a septic 98 
nor an acute haemolytic transfusion reaction were suspected, then a febrile non‐haemolytic transfusion 99 
reaction was recorded. In these cases, the transfusion was stopped temporarily, the patient was monitored 100 
and the transfusion was restarted if the temperature normalised. Transfusion‐associated circulatory overload 101 
was recorded if a cat developed respiratory distress (defined as increased effort and respiratory rate >40 102 
breaths per minute) during or within 24 hours after the transfusion, echocardiography performed by the 103 
attending clinician demonstrated an enlarged left atrium (with a left atrium‐to‐aorta ratio >1.5) and the 104 
respiratory distress resolved with treatment with furosemide. Other causes of respiratory distress, including 105 
transfusion‐related acute lung injury were investigated if transfusion‐related circulatory overload was not 106 
diagnosed. A delayed haemolytic transfusion reaction was recorded if a patient developed haemolysed serum 107 
and/or haemoglobinuria, an increase in total bilirubin or bilirubinuria and concurrent decrease in PCV more 108 
than 24 hours after transfusion that could not be explained by any concurrent disease process. Serum 109 
creatinine concentration was measured at approximately 24 hours and 5 days after transfusion (deemed the 110 
time when a delayed haemolytic transfusion reaction was likely) at the attending clinician's discretion, to 111 
assess for acute kidney injury secondary to the haemoglobinaemia caused by a haemolytic reaction. 112 
 113 
For cats that survived to discharge, referring veterinary practices were contacted and asked for an update on 114 
the cats in the study. For those that were still alive, owners were contacted with a standardised telephone 115 
questionnaire (document 2, Supporting Information) incorporating five set questions with progression to the 116 
next question only if xenotransfusion was not mentioned in the previous answer. The number of questions 117 
(from 1 to 5) asked to prompt mention of xenotransfusion was recorded. The owners were then asked if any 118 
warning had been given to them regarding future treatments and also if their cat had fully recovered from its 119 
disease. 120 
 121 
Ethical approval was granted for this study by the university teaching hospital Ethics and Welfare committee 122 
(ref: SR2017‐1162).  123 
 124 
Statistical analysis 125 
Statistical analyses were performed using the statistical software Tanagra version 1.4.50 (Lyon, France, 126 
2003). Data were analysed and presented as median ± range. Data were assessed for normality using the 127 
Shapiro‐Wilk test. Paired t tests were used to examine whether creatinine values were significantly different 128 
before and after xenotransfusion and chi squared test or Fisher's exact test was used to assess the 129 
association of the results of crossmatch with transfusion reactions. Differences were considered significant 130 




Forty‐nine cats received a xenotransfusion between January 2016 and July 2018 and were included in this 135 
study. The protocol was followed in all cases. Twenty‐three were neutered females, three were entire females 136 
and 23 were neutered males. Twenty‐eight were domestic shorthair cats, four were domestic long hairs, four 137 
were British shorthairs, three were Bengals, two were Persians, two were Siamese, two were ragdolls and one 138 
each was Burmese, Chantilly‐Tiffany, Tonkinese and Abyssinian. Median age was 8.0 years old [range 0.6 to 139 
16.5 years]. 140 
 141 
The most common reasons for anaemia were surgical blood loss (17 of 49, 34.7%) with the xenotransfusion 142 
either given intra‐ (five of 17 cases) or post‐operatively (12 of 17 cases), immune‐mediated haemolytic 143 
anaemia (IMHA, eight regenerative IMHA and six non‐regenerative; 14 of 49, 28.6%) and neoplasia (14 of 49, 144 
28.6%). There was one case each of inflammatory bowel disease, coagulopathy of undetermined cause, acute 145 
kidney injury and oral ulcerations (feline eosinophilic granuloma). Nine cats (nine of 49, 18.4%) had received 146 
a feline blood transfusion of feline packed red blood cells before the xenotransfusion. 147 
 148 
Blood tests 149 
Thirty cats were blood type A (61.2%), 14 were type B (28.6%) and three (6.1%) were type AB. Two cats were 150 
not blood typed (one was administered a xenotransfusion during cardiopulmonary resuscitation and one was 151 
deemed at risk of imminent cardiopulmonary arrest and died within 2 hours of starting the xenotransfusion). 152 
Median PCV before transfusion was 10% [Range 4 to 16%]. 153 
 154 
Crossmatches between the feline recipients and the donated dog blood were performed in 29 cases. Major 155 
crossmatches were incompatible in 20 of 29 cases (69.0%) and minor crossmatches were incompatible in eight 156 
of 26 cases (30.8%) (with three minor crossmatches being non‐interpretable due to the recipient being saline 157 
agglutination positive). Both major and minor crossmatches were incompatible in six of 29 cases (20.7%) and 158 
both crossmatches were compatible in seven of 29 cases (24.1%). Major and minor crossmatches only were 159 
incompatible in 14 of 29 cases (48.3%) and two of 29 cases (6.9%), respectively.  160 
 161 
Transfusion 162 
Thirty‐five cats (35 of 49, 71.4%) received DEA‐1‐positive packed red blood cells and 14 received DEA‐1‐163 
negative packed red blood cells (14 of 49, 28.6%). The median volume transfused was 14.6 mL/kg [range 2.6 164 
to 28.0 mL/kg]. Six cats (six of 49, 12.2%) had a febrile non‐haemolytic transfusion reaction during the 165 
xenotransfusion. For two of these cats, the xenotransfusion was stopped (for 20 minutes in one case and 166 
2 hours in the other) and was then continued when their temperature normalised. For one cat, the reaction 167 
occurred towards the end of the transfusion and it was not restarted because the temperature remained 168 
elevated. The occurrence of febrile non‐haemolytic transfusion reaction was not significantly different 169 
between cats with a compatible or incompatible crossmatch (P = 0.75). No other acute transfusion reactions 170 
were noted. 171 
 172 
Short-term outcome 173 
PCV after transfusion was obtained in 39 cases. Five cats died or were euthanased during the xenotransfusion 174 
(one was undergoing cardiopulmonary resuscitation when the xenotransfusion started, two were euthanased 175 
due to the results of diagnostics that were performed during this time (biliary carcinoma and pulmonary 176 
thromboembolism) and two did not stabilise, leading to the recommendation for euthanasia). Three cats were 177 
euthanased before the 12‐hour PCV check because of poor prognosis associated with the primary disease 178 
(gastro‐intestinal large granular lymphocytic lymphoma, ulcerative gastropathy and subcutaneous 179 
haemangiosarcoma) and two cats survived but did not have a PCV reported 12 hours after the 180 
xenotransfusion. Median PCV was 25% [range 10 to 50%], when evaluated at a median of 12 hours [range 4 181 
to 14 hours] after xenotransfusion. Two cats (one with gastric lymphoma and one with diffuse splenic and 182 
hepatic neoplasia) went home between 12 and 24 hours after xenotransfusion to be euthanased by their 183 
referring veterinary surgeons. 184 
 185 
Of the remaining 39 patients (39 of 49), a delayed haemolytic transfusion reaction occurred in 25. Haemolytic 186 
serum was noted in 19 of 25 cats after a median of 2 days [range 1 to 6 days], and icterus or icteric serum in 187 
15 of 25 cats after a median of 1.9 days [range 1 to 6 days]. Nine cats had both haemolysed and icteric serum. 188 
Of the 14 cats without delayed haemolytic transfusion reaction, nine died or were discharged from the hospital 189 
for euthanasia at home due to their underlying disease within 48 hours of the end of the xenotransfusion. The 190 
remaining five were hospitalised for at least 6 days after xenotransfusion without developing overt 191 
haemolysis, but one of them did receive a feline packed red blood cell transfusion 3 days later. Of the 25 cats 192 
that developed a delayed haemolytic transfusion reaction, 14 (of 25) were discharged from the hospital, 193 
among which one was discharged within 48 hours after xenotransfusion for euthanasia at home and two of 194 
them died or were euthanased within a week. Overall, 14 cats (of 39) were administered a cat blood 195 
transfusion after a median of 4 days [range 1 to 6 days]. 196 
 197 
Of the 20 cats with incompatible major crossmatch, 12 (12, 60%) developed a delayed haemolytic transfusion 198 
reaction compared to three out of nine cats (33.3%) that were major crossmatch compatible. Two of the eight 199 
cats with incompatible minor crossmatch and 10 of 18 (55.6%) cats with compatible crossmatch developed a 200 
delayed haemolytic transfusion reaction (Table 1). Major or minor crossmatch did not apparently differ in the 201 
occurrence of delayed haemolytic transfusion reaction (respectively P = 0.24 and P = 0.28). Delayed haemolytic 202 
transfusion reactions occurred at a median of 2 days [range 1 to 6 days] after xenotransfusion in patients with 203 
incompatible major crossmatch and 1 day [range 1 to 1.5 days] in cats that received compatible blood on major 204 
crossmatch. Incompatibly on major crossmatch did not significantly affect the time between xenotransfusion 205 
and development of a delayed haemolytic transfusion reaction (P = 0.26). However, time between 206 
xenotransfusion and discharge for the crossmatched patients was a median of 2 days [range 0 to 16 days] and 207 
21 of 29 (72.4%) patients were discharged or died before 6 days after xenotransfusion. 208 
 209 
Twenty‐three cats of the original population of 49 (46.9%) were discharged from the hospital. Five of these 23 210 
cats (21.7%) died or were euthanased within a week after xenotransfusion: two were diagnosed with 211 
leukaemia, two with hepatic and splenic neoplasia and one with gastric lymphoma. Of the remaining 18 cats 212 
which survived more than 1 week after xenotransfusion, 11 (61.1%) had had a delayed haemolytic transfusion 213 
reaction. However, five of seven cats that did not develop a delayed haemolytic transfusion reaction were 214 
discharged before 7 days after xenotransfusion. Ten of the 18 surviving cats (55.6%) were administered a cat 215 
blood transfusion after a median of 4 days [range 2 to 6] after xenotransfusion. 216 
 217 
Creatinine 218 
Creatinine measurements before and 1 day after xenotransfusion were available for 20 cats and at 219 
approximately 5 days after xenotransfusion (median 4 days [range 2 to 10]) for 13 cats (Table 2). Median 220 
value was 142 μmol/L [range 54 to 800 μmol/L] before and 108 μmol/L [range 52 to 824 μmol/L] at 1 day and 221 
100 μmol/L [range 50 to 1099 μmol/L] at approximately 5 days after xenotransfusion. 222 
 223 
Urine specific gravity was available for 12 cases before xenotransfusion. Among the 22 cats for which a 224 
creatinine measurement was recorded before xenotransfusion, seven were azotaemic (creatinine 225 
>140 μmol/L). Six of these azotaemic cats had a urine specific gravity of less than 1.035 (Table 2). 226 
 227 
Long-term outcome 228 
Eighteen cats (18 of 49, 36.7%) were still alive 7 days after xenotransfusion. Of these 18, nine (50.0%) 229 
received a xenotransfusion for surgical blood loss, six (33.3%) for IMHA, two for neoplasia (11.1%) and one 230 
for inflammatory bowel disease (5.6%). One cat, diagnosed with mesenteric and splenic large cell lymphoma, 231 
was euthanased 10 days after xenotransfusion due to lack of response to chemotherapy, and one was 232 
euthanased 184 days after xenotransfusion due to a relapse of IMHA. 233 
 234 
All surviving cats' owners were contacted, at a median of 173 days [range 157 to 570 days] after 235 
xenotransfusion. One cat was lost to follow‐up, so 15 owners were questioned. A median of two questions 236 
[range 1 to 5] was necessary for the owners to mention the xenotransfusion, with all owners stating that 237 
their cat had received a xenotransfusion by question 5. Nine owners (of 15, 60.0%) remembered their cat 238 
could not receive a repeat xenotransfusion. Eight cats were reported to be recovered from their primary 239 
disease, all of which had received a xenotransfusion for surgical blood loss. 240 
 241 
Discussion 242 
This study is the first to examine the long‐term outcome of a large number of clinical feline recipients of 243 
canine blood. The most common reason for xenotransfusion administration was surgical blood loss. The 244 
urgency and unpredictability of these situations explains the use of xenotransfusions, because it was not 245 
possible to find a cat donor sufficiently rapidly. The hospitals involved in this study do not have access to in‐246 
house donors or a national cat blood bank (as is common for many veterinary surgeons around the world), 247 
and so organising a feline donation relies on contacting an owner with a cat on the donation list and 248 
arranging a donation for a mutually convenient time which can be many hours or even days after the urgent 249 
need for blood has arisen (Doolin et al. 2017). 250 
 251 
The high level of adherence to the protocol minimised potential unnecessary use of xenotransfusion and 252 
suggests that xenotransfusions were only used in urgent situations where the cat was thought likely to die 253 
within the next 6 hours. Canine to feline xenotransfusion described previously also mainly involved life‐254 
threatening situations (Oron et al. 2017, Euler et al. 2016, Klainbart et al. 2018); although lack of affordability 255 
of cat blood is also a suggested indication (Weingram et al. 2014, Klainbart et al. 2018). The protocol 256 
described in this study could be used by any clinician to help decide whether a xenotransfusion is 257 
appropriate, with objective parameters and specific indications. In the protocol described here, the 258 
attending clinician needed to review the case with a member of the Transfusion Medicine Service and both 259 
had to agree to the patient's suitability for xenotransfusion, but in primary care practice this step could be 260 
substituted with a colleague, meaning that each case is carefully considered for suitability. 261 
 262 
The proportion of cats developing a febrile non‐haemolytic transfusion reaction in this study was 263 
comparable to that reported in a previous smaller study of xenotransfusions in which 10% (two of 20) of cats 264 
developed hyperthermia, although it was unclear whether other possible transfusion reactions that could 265 
cause an elevated temperature had been excluded (René 1968). Interestingly, similar febrile non‐haemolytic 266 
transfusion reaction rates of 13 and 29%, for crossmatch compatible and non‐crossmatched blood 267 
respectively, were reported in a recent prospective study of cat blood administration to cats (Sylvane et al. 268 
2018) but other studies have a much lower rates of 2.2 to 2.5% (Castellanos et al. 2004, Weingart et al. 2004, 269 
Klaser et al. 2005, Roux et al. 2008, McClosky et al. 2018). Given the latter studies were retrospective or 270 
surveys, it is possible that febrile non‐haemolytic transfusion reactions were overlooked and that there is 271 
little difference in febrile non‐haemolytic transfusion reaction rate between cat and dog blood 272 
administration to cats. In a recent study (Sylvane et al. 2018), febrile non‐haemolytic transfusion reactions 273 
did not appear to be associated with crossmatch incompatibilities between donor and recipient blood; our 274 
findings were similar, although further studies with more crossmatched cases would be required for 275 
confirmation. 276 
 277 
Two cases were euthanased during xenotransfusion because they failed to stabilise and, although the signs 278 
they displayed were not suggestive of an acute transfusion reaction, they could have been secondary to the 279 
xenotransfusion and were difficult to interpret in a critical patient. 280 
 281 
Our results may under‐report the incidence of delayed haemolytic transfusion reaction because nine of 14 282 
cats in which it was not detected died or were discharged from hospital within 48 hours of the 283 
xenotransfusion. Furthermore, of the remaining five cats without signs of a febrile non‐haemolytic 284 
transfusion reaction (which were hospitalised for at least 6 days post‐xenotransfusion), one cat diagnosed 285 
with IMHA was administered a cat blood transfusion 3 days after xenotransfusion, which suggests 286 
haemolysis might have been overlooked or that haemolysed serum or haemoglobinuria was not displayed by 287 
this patient. 288 
 289 
Delayed haemolytic transfusion reactions occurred after a mean of 2.3 days but there was evidence of 290 
haemolysis as early as 1 day after the end of xenotransfusion administration in nine cases. The latest day 291 
that evidence of haemolysis was first apparent was 6 days after xenotransfusion. Incompatibilities between 292 
donors and recipients did not predict the development of a delayed haemolytic transfusion reaction or 293 
influence the time between the xenotransfusion and the occurrence of a delayed haemolytic transfusion 294 
reaction although in vitro results of major crossmatch between a canine donor and a feline recipient suggest 295 
a potential high risk of acute transfusion reactions (Priolo et al. 2018). Haemolysis following xenotransfusion 296 
can therefore occur much earlier than suggested by previous studies in which haemolysis was reported to 297 
occur at day 4 to 7 (Bovens & Gruffydd‐Jones 2013). 298 
 299 
Creatinine monitoring was only available in a limited number of cases but showed azotaemia was frequent 300 
after xenotransfusion. Most of the azotaemic cats had a urine specific gravity of less than 1.035 suggesting 301 
renal azotaemia. Unfortunately, specific gravity was not measured concurrent with creatinine measurement 302 
after xenotransfusion and so whether any azotaemia detected was genuinely renal in origin cannot be 303 
determined, although by this point the cats had been hospitalised for several days and were monitored for 304 
hydration or volume deficits and should have been normally hydrated. No significant difference in creatinine 305 
levels was apparent after xenotransfusion which would suggest that marked acute kidney injury did not 306 
occur secondary to haemoglobinaemia due to a delayed haemolytic transfusion reaction. However, 307 
assessment of kidney injury with creatinine alone is suboptimal. Ideally, concurrent measurement of urine 308 
specific gravity and sediment analysis would have been performed as recommended by the IRIS acute kidney 309 
injury guidelines (Cowgill 2012). 310 
 311 
All the non‐surviving cats in this study died or were euthanased because of their underlying disease process 312 
with long‐term follow‐up showing no evidence of complications of xenotransfusion after the delayed 313 
haemolytic transfusion reactions at 1 to 6 days. It is impossible to state definitively that the xenotransfusions 314 
did not contribute to mortality in this study, but the reasons for death or euthanasia given by the attending 315 
clinicians described underlying disease process progression. 316 
 317 
Owners received verbal instructions when they gave consent for the xenotransfusion and a written warning 318 
was handed to them with their discharge because it has been shown to increase retention of information in 319 
human medicine (Johnson et al. 2003). Follow‐up showed that owners generally remembered that their cat 320 
had had a xenotransfusion, but that they were less reliably aware that a repeat xenotransfusion was not 321 
advisable. Strict protocols and excellent communication between veterinary practices therefore need to be 322 
in place to make sure that repeat xenotransfusion is avoided. 323 
 324 
Although there are clearly concerns about the use of xenotransfusion, most prominently the high frequency 325 
of delayed haemolytic transfusion reactions meaning that many cats in this study required a further feline 326 
blood transfusion and the previously described risk of death with repeat transfusion (Bovens & Gruffydd‐327 
Jones 2013), there can be benefits to xenotransfusion administration in certain circumstances. First, in 328 
emergencies, the period between a xenotransfusion and likely delayed haemolytic transfusion reaction 329 
provides the clinician with the opportunity to source compatible feline blood if necessary. In cats with 330 
adequate regeneration, a second transfusion of feline blood may not be required, as was the case in seven 331 
of 18 cats that survived over a week after discharge. Secondly, administration of a xenotransfusion may 332 
allow further investigations to be pursued, if the prognosis of the cat is expected to be poor or for owners to 333 
have more time to consider their options, including euthanasia in terminal cases. Clinicians may also have 334 
ethical concerns about using feline blood products in patients with a guarded prognosis due to the generally 335 
accepted greater impact donation has on cats compared to dogs (Taylor & Humm 2016). This could well have 336 
been relevant in this study given 31 of 49 cats had died by day 7 after xenotransfusion. 337 
 338 
There were several limitations to this study. Although well defined, identification of acute and delayed 339 
transfusion reactions required appropriate monitoring. A standardised protocol was used during the 340 
xenotransfusion, to maximise recognition of acute transfusion reactions. However, delayed transfusion 341 
reactions could have been overlooked because some patients died or were discharged from the hospital 342 
before the 7 days previously reported as the latest time a delayed haemolytic transfusion reaction could 343 
occur after xenotransfusion (Bovens & Gruffydd‐Jones 2013). Also, as this was a clinical study, blood 344 
sampling allowing identification of icteric or haemolysed serum did not occur in a standardised fashion, 345 
although it was generally performed daily. The minimum monitoring was a once daily full physical 346 
examination; however, these cases were critically ill initially and received very close monitoring during this 347 
critical period in all cases. 348 
 349 
Additionally, some tests were only performed on a subset of our cohort (crossmatches and creatinine 350 
measurements). These tests were not imposed in the protocol due to the limited availability of blood in 351 
these critical patients and were left at the clinician's discretion. Therefore, further studies with more cases 352 
are required to investigate the trends outlined here. 353 
 354 
It is also worth noting that there are no standardised guidelines regarding transfusion reactions in veterinary 355 
medicine. Therefore, a delayed haemolytic transfusion reaction was diagnosed in this study using compatible 356 
clinical signs. In human medicine, delayed haemolytic transfusion reaction is classed as definitive by the 357 
Centres of Disease Control and Prevention when development of novel antibodies can be demonstrated 358 
after transfusion in conjunction with a rapid decrease in PCV back to pre‐transfusion levels (U.S. Centers for 359 
Disease Control and Prevention 2018). Antibodies were not measured in our cases, but the clinical signs seen 360 
in the patients were compatible with a delayed haemolytic transfusion or haemolysis (rapid decrease in PCV 361 
and development of jaundice which self‐resolves) as described by the CDC (U.S. Centers for Disease Control 362 
and Prevention 2018). 363 
 364 
In conclusion, this study demonstrates that xenotransfusion of canine blood to cats is a potentially life‐saving 365 
procedure in emergencies when feline blood products are not available. No acute adverse reactions other 366 
than febrile non‐haemolytic transfusion reactions (which are short‐lived and self‐limiting) were seen in this 367 
study. Delayed haemolytic transfusion reactions are to be expected between 1 and 6 days after 368 
xenotransfusion. Close monitoring of cats that receive a xenotransfusion is therefore advised because feline 369 
blood products may be rapidly required. 370 
 371 
The protocol used here was followed by clinicians and could be easily adapted for use in other clinics. For 372 
some veterinarians the need for the administration of a xenotransfusion will never arise, but for those 373 
working without access to feline blood banks or stored feline blood products, this information should 374 
increase confidence that xenotransfusion can be performed. It also allows understanding of the adverse 375 
effects that can arise, meaning owners can be fully informed and appropriate patient monitoring performed. 376 
Finally, our study shows that the long‐term outcome for these cats appears to be associated with their 377 
primary disease and those who recover from this have no notable adverse effects that could be directly 378 
attributed to xenotransfusion. 379 
  380 
Table 1. Occurrence of reaction depending on crossmatch results 381 











after (median in 
days post 
transfusion) 
Major and minor 
cross matches 
incompatible 6 2 0 2 0 3 1 1 2 [0 to 3] 
Major cross 
match 
incompatible 14 2 8 6 4 5 4 2 2.5 [0 to 16] 
Minor cross 
match 
incompatible 2 0 0 0 0 2 2 2 5 [0 to 10] 
Compatible 
minor and major 




reaction          
 382 
  383 
Table 2. Creatinine measurements pre and post‐xenotransfusion 384 
  Creatinine pre‐
xenotransfusion 
(μmol/L) 












Cat 1 270   238 1099 4 
Cat 2 726 1.011 824     
Cat 3 219 1.026 228 603 5 
Cat 4 800 1.014 741 671 5 
Cat 5 69   125     
Cat 6 155   172     
Cat 7 57   68 50 2 
Cat 8 252   321     
Cat 9 73 1.032 64 69 3 
Cat 10 339 1.02 114 68 6 
Cat 11 74 1.023 61     
Cat 12 144 1.038 108 100 2 
Cat 13 94 1.018 98 79 6 
Cat 14 66   97     
Cat 15 155 1.012 214     
Cat 16 142   96     
Cat 17 181   69 75 2 
Cat 18 455 1.018 242 212 2 
Cat 19 81   64 181 2 
Cat 20 76 1.032 52     
Cat 21 88     57 10 
Cat 22 54 1.025   120 4 
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